Related Experiment Video
Updated: Jan 6, 2026
13:21
Graphene Coatings for Biomedical Implants
Published on: March 1, 2013
21.7K
New Insights into the Interaction between Graphene Oxide and Beta-Blockers
Yuehua Deng1,2, Yani Li3,4, Wenjie Nie5,6
1College of Geology and Environment, Xi'an University of Science and Technology, Xi'an 710054, China. yhdeng2018@xust.edu.cn.
Nanomaterials (Basel, Switzerland)
|October 12, 2019
Summary
Magnetic graphene oxide (GO/Fe3O4) effectively removes propranolol (PRO) from water. This study highlights GO/Fe3O4 as a promising adsorbent for pharmaceutical pollutant removal.
Area of Science:
- Environmental Science
- Materials Science
- Chemistry
Background:
- Pharmaceuticals like propranolol (PRO) are emerging contaminants in water.
- Efficient removal methods for PRO are crucial for environmental protection.
- Magnetic graphene oxide (GO/Fe3O4) is a novel nanomaterial with potential adsorbent properties.
Purpose of the Study:
- To synthesize and characterize GO/Fe3O4 as a nano-adsorbent.
- To investigate the adsorption of PRO onto GO/Fe3O4 under various environmental conditions.
- To elucidate the adsorption mechanism and kinetics.
Main Methods:
- Synthesis of magnetic graphene oxide (GO/Fe3O4) nanocomposite.
- Characterization using SEM, TEM, VSM, FTIR, XRD, zeta potential, and XPS.
- Batch adsorption experiments to study the effects of pH, humic acid, PRO concentration, and contact time.
- Analysis of adsorption kinetics and isotherms using pseudo-first-order, pseudo-second-order, Langmuir, Freundlich, and Sips models.
Main Results:
- GO/Fe3O4 was successfully synthesized and characterized.
- Adsorption of PRO onto GO/Fe3O4 was significantly influenced by pH, humic acid concentration, PRO concentration, and contact time.
- Adsorption kinetics followed both pseudo-first-order and pseudo-second-order models.
- Adsorption isotherms were well-described by Langmuir, Freundlich, and Sips models, indicating complex adsorption mechanisms.
- Electrostatic attraction, hydrogen bonding, and π-π interactions were identified as key mechanisms.
Conclusions:
- GO/Fe3O4 is a highly feasible and effective nano-adsorbent for removing propranolol from aqueous solutions.
- The study expands the application scope of graphene oxide-based nanomaterials in water treatment.
- This research provides valuable insights into the removal of pharmaceutical pollutants using magnetic nanomaterials.
More Related Videos
Related Concept Videos
01:28Antihypertensive Drugs: Types of β-Blockers
1.4K
β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and...
1.4K
01:27Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
1.5K
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
1.5K
01:25Adrenergic Antagonists: Chemistry and Classification of β-Receptor Blockers
1.2K
β-adrenergic antagonists, or β-blockers, modulate the sympathetic nervous system by targeting β-adrenoceptors and inhibiting catecholamine-mediated sympathetic responses. β-blockers differ in their adrenoceptor subtype affinity, lipophilicity, and α-blocking capabilities. The history of β-blocker development began with the prototype, dichloroisoprenaline, which exhibited partial agonist activity. As a result, propranolol was developed as a pure antagonist but...
1.2K
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
1.3K
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
1.3K
01:22Heart Failure Drugs: β-Blockers
721
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
721
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
1.1K
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
1.1K